Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP341699.RA7Z5iDZrxj3VyAHuO-NeSiz23N0oGg6sXc07whlHjZY4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP341699.RA7Z5iDZrxj3VyAHuO-NeSiz23N0oGg6sXc07whlHjZY4130_assertion type Assertion NP341699.RA7Z5iDZrxj3VyAHuO-NeSiz23N0oGg6sXc07whlHjZY4130_head.
- NP341699.RA7Z5iDZrxj3VyAHuO-NeSiz23N0oGg6sXc07whlHjZY4130_assertion description "[Breast tumors with ERBB2 amplification expressed, on average, approximately 20 times (P < 0.001) higher mRNA levels than prostate tumors or breast carcinomas without the gene amplification.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP341699.RA7Z5iDZrxj3VyAHuO-NeSiz23N0oGg6sXc07whlHjZY4130_provenance.
- NP341699.RA7Z5iDZrxj3VyAHuO-NeSiz23N0oGg6sXc07whlHjZY4130_assertion evidence source_evidence_literature NP341699.RA7Z5iDZrxj3VyAHuO-NeSiz23N0oGg6sXc07whlHjZY4130_provenance.
- NP341699.RA7Z5iDZrxj3VyAHuO-NeSiz23N0oGg6sXc07whlHjZY4130_assertion SIO_000772 11786427 NP341699.RA7Z5iDZrxj3VyAHuO-NeSiz23N0oGg6sXc07whlHjZY4130_provenance.
- NP341699.RA7Z5iDZrxj3VyAHuO-NeSiz23N0oGg6sXc07whlHjZY4130_assertion wasDerivedFrom befree-2016 NP341699.RA7Z5iDZrxj3VyAHuO-NeSiz23N0oGg6sXc07whlHjZY4130_provenance.
- NP341699.RA7Z5iDZrxj3VyAHuO-NeSiz23N0oGg6sXc07whlHjZY4130_assertion wasGeneratedBy ECO_0000203 NP341699.RA7Z5iDZrxj3VyAHuO-NeSiz23N0oGg6sXc07whlHjZY4130_provenance.